Impact of evaluation for cardio-vascular examination especially for anemia treatment for left ventricular remodeling during before initiation of dialysis in chronic kidney disease patients
Not Applicable
- Conditions
- chronic kidney disease patients
- Registration Number
- JPRN-UMIN000018312
- Lead Sponsor
- Juntendo University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
not inclusion criteria
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method left ventricular remodeling
- Secondary Outcome Measures
Name Time Method cardio-vascular events patency of arterio-venus fistula
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Pathophysiology linking CKD-associated anemia, ESA therapy, and left ventricular remodeling progression.
Comparative effectiveness ESAs versus iron therapy on LVH regression pre-dialysis CKD patients.
Biomarkers (FGF23, BNP, troponin) predicting cardiovascular events CKD patients undergoing anemia treatment.
Cardiovascular safety concerns erythropoiesis-stimulating agents versus HIF-PH inhibitors in pre-dialysis CKD.
Role intensive cardiovascular monitoring managing LVH progression pre-dialysis CKD patients anemia.